Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in Q2 2018?

92 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 00461U105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, $0.00001 par value per share
Shares outstanding: 121,058,810
Total 13F shares: 30,998,695
Share change: +432,510
Total reported value: $618,964,700
Put/Call ratio: 79%
Price per share: $19.97
Number of holders: 92
Value change: +$11,707,281
Number of buys: 51
Number of sells: 42

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 00461U105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.3%	2,745,705	$48,105,000	—	31 Mar 2018	13F
FRANKLIN RESOURCES INC	13F	Company	2.1%	2,575,391	$45,121,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	2.1%	2,558,980	$44,834,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	1.7%	2,107,426	$36,921,000	—	31 Mar 2018	13F
Polar Capital LLP	13F	Company	1.4%	1,650,715	$28,921,000	—	31 Mar 2018	13F
Vivo Capital, LLC	13F	Company	1.4%	1,647,214	$28,859,000	—	31 Mar 2018	13F
Sofinnova Investments, Inc.	13F	Company	1.3%	1,539,480	$26,972,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	1%	1,238,286	$21,695,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.96%	1,167,429	$20,454,000	—	31 Mar 2018	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.81%	985,976	$17,274,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.74%	896,837	$15,712,000	—	31 Mar 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.7%	851,774	$14,923,000	—	31 Mar 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.6%	730,374	$12,796,000	—	31 Mar 2018	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.59%	710,369	$12,446,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	0.57%	686,591	$12,029,000	—	31 Mar 2018	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.49%	591,176	$10,357,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	0.48%	575,954	$10,091,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.47%	563,162	$9,867,000	—	31 Mar 2018	13F
Rock Springs Capital Management LP	13F	Company	0.44%	530,000	$9,286,000	—	31 Mar 2018	13F
LOOMIS SAYLES & CO L P	13F	Company	0.44%	527,228	$9,237,000	—	31 Mar 2018	13F
Cormorant Asset Management, LP	13F	Company	0.43%	525,538	$9,207,000	—	31 Mar 2018	13F
Foresite Capital Management IV, LLC	13F	Company	0.35%	429,551	$7,526,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.32%	391,662	$6,862,000	—	31 Mar 2018	13F
Foresite Capital Management III, LLC	13F	Company	0.26%	312,368	$5,473,000	—	31 Mar 2018	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.25%	300,000	$5,256,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.24%	295,571	$5,179,000	—	31 Mar 2018	13F
AXA S.A.	13F	Company	0.24%	294,698	$5,163,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	244,870	$4,290,000	—	31 Mar 2018	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.17%	211,797	$3,711,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.17%	202,818	$3,553,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.16%	190,281	$3,333,000	—	31 Mar 2018	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.12%	140,000	$2,453,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	125,569	$2,200,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.1%	116,578	$2,042,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	110,827	$1,942,000	—	31 Mar 2018	13F
Redmile Group, LLC	13F	Company	0.09%	106,820	$1,871,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	99,422	$1,742,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	97,392	$1,705,000	—	31 Mar 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.07%	81,491	$1,428,000	—	31 Mar 2018	13F
HighTower Advisors, LLC	13F	Company	0.06%	77,816	$1,364,000	—	31 Mar 2018	13F
C WorldWide Group Holding A/S	13F	Company	0.06%	75,265	$1,319,000	—	31 Mar 2018	13F
Capital Impact Advisors, LLC	13F	Company	0.06%	69,107	$1,211,000	—	31 Mar 2018	13F
A.R.T. Advisors, LLC	13F	Company	0.05%	57,300	$1,003,000	—	31 Mar 2018	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.05%	56,109	$983,000	—	31 Mar 2018	13F
Telemetry Investments, L.L.C.	13F	Company	0.05%	56,000	$981,000	—	31 Mar 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.04%	49,450	$867,000	—	31 Mar 2018	13F
AXIOM INVESTORS LLC /DE	13F	Company	0.04%	47,580	$834,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.04%	45,828	$804,000	—	31 Mar 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.04%	45,111	$790,000	—	31 Mar 2018	13F
ROSENBLUM SILVERMAN SUTTON S F INC /CA	13F	Company	0.04%	44,200	$774,000	—	31 Mar 2018	13F

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q2 2018

As of 30 Jun 2018, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,998,695 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., Polar Capital LLP, Vivo Capital, LLC, Sofinnova Ventures Inc, D. E. Shaw & Co., Inc., VANGUARD GROUP INC, and CITADEL ADVISORS LLC. This page lists 92 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

100

Q2 2018 holders

Holder diff

-8

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.